[Webinar] The Complexities of Pediatric Rare Disease Trials: Regulatory and Operational Strategies for Success
January 25, 2022 at 01:57 pm EST
Share
Strategic planning and execution are crucial when implementing rare disease clinical trials, especially when factoring in the added complexities of pediatric rare disease trials.
There are many operational and regulatory challenges to consider when planning for pediatric rare disease clinical trials. Without careful, strategic planning to tackle these challenges, trials may be fraught with operational hurdles which can delay recruitment and other study milestones. Understanding potential challenges and pitfalls and setting realistic regulatory expectations are critical when developing study timelines and strategies.
Join Medpace experts on Rare Disease Day as they share operational and regulatory challenges associated with pediatric rare disease clinical trials, along with strategies to help anticipate and overcome them.
Register Now
Learn more about Medpace's capabilities in rare disease and pediatrics.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Medpace Holdings Inc. published this content on 25 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 January 2022 18:56:04 UTC.
Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.
MEDPACE HOLDINGS, INC. 
